Epilepsy is among the most common neurological diseases, affecting 0.5-1% of the general population. Epilepsy is also among the most frequently diagnosed neurological paediatric disorders, with long-term implications for the quality of life of those affected. Only in two-thirds of cases, seizures can be adequately controlled with anticonvulsant drug treatment. For the remaining drug-refractory patients with focal epilepsy, surgery is currently the most effective treatment. However, only 15-20% of those patients are eligible for epilepsy surgery. PerEpi aims to bring together a group of experts at the European level to improve this situation in two ways. The first one focuses on a new individualised multimodal approach to offer the most appropriate personalised therapy. The second one focuses on a new individually optimized transcranial electric brain stimulation technique as a new treatment which is attractive for those focal refractory patients, where surgery is not an option.

2021

2024